TOP TIERMARKET NEWSWIRE
News & sentiment

ORUKA THERAPEUTICS I (ORKA) — News & AI sentiment

ORUKA THERAPEUTICS I (ORKA) news roundup. 14 stories in the past week, 18 over 30 days. Average 30-day sentiment is 59.8/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 16 sales totalling $22.0M — net selling of $22.0M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
14
avg sentiment 59.9/100
30d stories
18
avg sentiment 59.8/100
Insider net (90d)
$22.0M
0 buys · 16 sells
Congress (90d)
0
0 buys · 0 sells

ORKA news in the last 24 hours, 7 days, 30 days and 90 days

How much ORKA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowORKA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days1459.9/100ORKA headlines →
Last 30 days1859.8/100ORKA headlines →
Last 90 days3657/100ORKA headlines →

Latest stories on ORKA

6d ago
6d ago
7d ago
7d ago
Oruka Therapeutics rises 14.3%
The Fly64 · neutralgeneral
7d ago
7d ago
Oruka Therapeutics Rises 11 6
The Fly64 · neutralgeneral
7d ago
Guggenheim reiterates Oruka Therapeutics stock rating on trial data
Investing.com Analyst Ratings52 · neutralanalyst
7d ago
7d ago
7d ago
7d ago
7d ago
7d ago
Oct 25
Oct 25
Oct 18
Oct 15
Oct 7
Sep 24
Sep 23
Sep 23
Sep 23
Oruka Therapeutics stock falls despite positive trial data
Investing.com Markets42 · neutralproduct/pr
Sep 23
Sep 23
Sep 23
Open ORKA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →